Skip to content

Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome

Baseline Assessment of Dietary Intake and Physical Activity in Women With Polycystic Ovary Syndrome (PCOS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01859663
Enrollment
126
Registered
2013-05-22
Start date
2013-05-31
Completion date
2022-05-31
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Habits, Physical Activity, Polycystic Ovary Syndrome

Keywords

Polycystic Ovary Syndrome (PCOS), Diet, Exercise, Questionnaires, Health Beliefs

Brief summary

The purpose of the study is to identify lifestyle factors associated with PCOS and understand how diet and activity levels impact features of PCOS. The secondary aim is to examine psychosocial factors (e.g., health beliefs) of women with PCOS.

Detailed description

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects 6-12% of reproductive-aged women within the general population. Currently, there is limited knowledge on the current lifestyles of women with PCOS and the psychosocial factors associated with PCOS. The researchers plan to examine potential lifestyle differences and psychosocial factors between PCOS and healthy women. The Research Team is also interested in the relationships between biological markers and lifestyle endpoints in women with and without PCOS. Previous literature has shown there are biological marker differences between those with and without PCOS. By examining these relationships, researchers may further understand whether PCOS status is associated with lifestyle parameters. To accomplish these objectives, 360 women (120 women with PCOS, 120 women without PCOS and with normal menstrual cycles, and 120 women without PCOS and with irregular menstrual cycles) will be included in this study. An equal number of lean and overweight/obese women will be recruited within each group based on body mass index (BMI; Lean = 18 - 24 kg/m2 and overweight/obese ≥ 25 kg/m2). Women will be included in the PCOS group if they have a confirmed PCOS diagnosis from their primary care provider. Participants will complete a food frequency questionnaire, a sleep questionnaire, and a physical activity questionnaire. A researcher may also provide participants with a waist-worn accelerometer to monitor physical activity and a wrist-worn accelerometer to monitor sleep for a week. Ultrasound scans of the ovaries will be assessed and the following metabolic parameters will be assessed: (1) 75-gram oral glucose tolerance test; (2) dual X-ray absorptiometry (DXA) scan; (3) vitals and anthropometry assessment to measure waist and hip circumference, height, weight, blood pressure, and heart rate; (4) fasting blood tests to detect androgens (i.e., total testosterone, androstenedione, free androgen index); and (5) an (optional) subcutaneous fat biopsy. Women with and without PCOS will also be asked to complete a questionnaire that will assess the psychosocial factors (e.g., health beliefs). This can be conducted online, in person, or through phone.

Interventions

None listed

Sponsors

University of Rochester
CollaboratorOTHER
Cornell University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 48 Years
Healthy volunteers
Yes

Inclusion criteria

* Between 18 and 48 years * BMI ≥ 18 kg/m2 * If ≥ 21 years old, must have completed a pelvic exam in the past 2 years * In PCOS if: Confirmed PCOS diagnosis from their primary care provider

Exclusion criteria

* Use of oral contraceptives, fertility medications, or any drugs known to influence reproductive function * Pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Differences in diet between women with and without PCOS1 weekA food frequency questionnaire will be administered to assess diet composition for the last three months.

Secondary

MeasureTime frameDescription
Differences in psychosocial factors (e.g., health beliefs) of women with and without PCOS1-2 weeksA questionnaire will be administered to assess psychosocial factors of women with PCOS.
Differences in sleep patterns between women with and without PCOS6 consecutive nightsA wrist-worn accelerometer will be administered to assess sleep patterns for 6 consecutive nights.
LH-FSH ratio1 dayThe ratio of circulating LH to FSH concentrations in the serum will be determined for each participant and compared across groups
Hirsutism Score1 dayDegree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups Degree of hirsutism as judged by the Ferriman-Gallwey scale will be determined and compared across groups
Androgen concentrations1 dayTotal testosterone, androstenedione and free androgen index concentrations in serum will be determined and compared across groups.
Menstrual Cycle Length1 dayAverage menstrual cycle length as determined by self-reported history will be determined and compared across groups
Body Mass Index1 dayThe ratio of weight to height will be determined and compared across groups.
Differences in exercise between women with and without PCOS1 weekAn accelerometer will be administered to assess physical activity for 1 week.
Ovarian Volume1 dayThe size of each ovary will be determined using ultrasonography for each participant during study participation and compared between groups.
Insulin Sensitivity1 dayInsulin sensitivity will be determined by administration of an oral glucose tolerance test and compared between groups.
Serum progesterone concentration1 dayThe serum progesterone concentration will be determined during study participation, assessed in association with luteal dynamics and compared between groups.
Blood pressure1 dayBlood pressure will be determined and compared between groups.
Serum markers of metabolic syndrome1 dayLipids, glucose and HbA1C concentrations will be determined and compared between groups.
Body fat distribution1 dayPercentage and distribution of fat and lean mass as assessed using DXA technology will be compared between groups.
Subcutaneous fat biopsy (optional)1 daySubcutaneous fat cells, which represent important sites of reproductive hormone synthesis, will be assessed and compared across groups
Waist-to-Hip Ratio1 dayThe ratio of waist circumference to hip circumference will be determined and compared across groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026